文献速递腹部介入MRUS

MRI上的瘤内脂肪能否预测超声引导下肿瘤消融时小(≤3 cm)肝细胞癌的超声可见性

Does intra-tumoural fat on MRI predict visibility of small (≤3 cm) hepatocellular carcinomas during ultrasound-guided tumour ablation?
PubMed 文献 · Clin Radiol · 2017-11-10

回顾性分析2010年1月1日至2015年4月31日间接受超声引导下射频消融的74例患者共90次操作,评估术前MRI瘤内脂肪对规划超声中小(≤3 cm)肝细胞癌可见性的预测价值。瘤内脂肪(p=0.005)和距膈肌距离(p=0.007)是影响超声可见性的显著因素,背景脂肪肝、肝硬化及肿瘤大小无显著影响。

要点

  • 术前MRI检测到瘤内脂肪是规划超声中肿瘤可见性的显著预测因素(p=0.005)。
  • 距膈肌距离也是超声可见性的显著影响因素(p=0.007)。
  • 背景脂肪肝(p=0.485)、肝硬化(p=0.48)和肿瘤大小(p=0.15)与超声可见性无显著相关。

核心结论

  • 术前MRI上小肝细胞癌的瘤内脂肪可准确预测其在经皮肿瘤消融规划超声中的可见性。

研究设计与样本

  • 回顾性研究,纳入2010年1月1日至2015年4月31日间接受图像引导消融的患者,共74例患者90次操作(62男12女,平均年龄67.3岁,范围39-88岁)。
  • 纳入标准为小肿瘤(≤3 cm)、初治病例或不同且未治疗段内的新发肝细胞癌灶、有术前MRI。
  • 通过同相位与反相位MRI回顾性判断瘤内脂肪存在,并记录背景脂肪肝、肝硬化、肿瘤大小及距膈肌距离等可能影响超声可见性的因素。

关键影像表现/征象

  • 90个肿瘤中72个在超声上可见,其中低回声35个、高回声28个、不均匀回声9个。
  • 23个肿瘤(25.6%)见瘤内脂肪,其中高回声17个、低回声6个。

诊断标准与关键数值

  • 瘤内脂肪存在(p=0.005)和距膈肌距离(p=0.007)为规划超声上肿瘤可见性的统计学显著影响因素。
  • 背景脂肪肝(p=0.485)、肝硬化(p=0.48)和肿瘤大小(p=0.15)与超声可见性无显著相关。

临床应用与阅片要点

  • 术前MRI评估瘤内脂肪有助于预测小肝细胞癌在超声引导消融规划时的超声可见性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess if intra-tumoural fat on magnetic resonance imaging (MRI) affects the ultrasonographic (US) visibility of small (≤3 cm) hepatocellular carcinomas (HCC) during radiofrequency ablation (RFA).

MATERIALS AND METHODS: Institutional review board approval was obtained. A retrospective review of all patients who underwent image-guided ablation between 1 January 2010 and 31 April 2015 was performed. Patients with HCC who underwent US RFA were included. Inclusion criteria included small tumours (≤3 cm), treatment-naive cases or new focus of HCC in a different and untreated segment, and pre-procedural MRI. The presence of intra-tumoural fat was determined retrospectively via in-and-out-of-phase MRI. Other factors that potentially affect ultrasonographic visibility, such as background fatty liver, presence of cirrhosis, tumour size, and distance from diaphragm, were recorded.

RESULTS: Ninety procedures performed on 74 patients (62 men and 12 women; mean age: 67.3 years; range: 39-88 years). Seventy-two tumours were visible on US (hypoechoic n=35, hyperechoic n=28, heterogeneous n=9). Intra-tumoural fat was seen in 23 tumours (25.6%, hyperechoic n=17, hypoechoic n=6). The presence of intra-tumoural fat (p=0.005) and distance from diaphragm (p=0.007) were found to be statistically significant factors affecting tumour visibility on planning US. The presence of background fatty liver (p=0.485), cirrhosis (p=0.48), and tumour size (p=0.15) were not found to be significant.

CONCLUSION: The present study shows that the presence of intra-tumoural fat in small HCCs on pre-procedural MRI can accurately predict their visibility on planning US during percutaneous tumour ablation.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Hui TCH, Huang IKH, Lau WK, et al. Does intra-tumoural fat on MRI predict visibility of small (≤3 cm) hepatocellular carcinomas during ultrasound-guided tumour ablation? Clin Radiol. 2017. PMID: 29129265. doi:10.1016/j.crad.2017.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。